Insider Trading June 24, 2026 06:23 PM

Ibotta CEO Bryan Leach Offloads $461K in Shares Under Pre-Arranged Trading Plan

Executed via Rule 10b5-1 framework, the sales coincide with recent stock momentum and a quarterly earnings miss, highlighting ongoing executive activity amid shifting valuation metrics.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
IBTA

Ibotta Inc. (NASDAQ: IBTA) Chief Executive Officer and President Bryan Leach has completed the sale of Class A common stock totaling $461,790 through two separate transactions on June 22 and June 23, 2026. The divestment was conducted under a Rule 10b5-1 trading plan established earlier in March 2026, a mechanism designed to facilitate predetermined stock sales regardless of market conditions. Concurrently, Leach exercised fully vested employee stock options to acquire an equivalent number of shares at a fixed exercise price, a standard practice that underscores the mechanical nature of the transaction rather than a discretionary market exit. The activity occurs against a backdrop of Ibotta's recent stock performance and its latest quarterly financial results, which revealed a significant earnings per share shortfall despite revenue meeting internal targets.

Ibotta CEO Bryan Leach Offloads $461K in Shares Under Pre-Arranged Trading Plan
IBTA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Ibotta CEO Bryan Leach sold $461,790 worth of Class A common stock via a Rule 10b5-1 plan on June 22 and 23, 2026, while simultaneously exercising options to acquire an equivalent number of shares.
  • The company reported a Q1 2026 EPS of $0.24, missing the $0.62 forecast by 61.29%, though revenue of $82.5 million slightly beat internal guidance despite a 2% year-over-year decline.
  • Needham raised its price target to $45 from $33, citing a higher target multiple, while the stock has gained 43% over six months, trading at $31.98.

Ibotta Inc. (NASDAQ: IBTA) Chief Executive Officer and President Bryan Leach has completed the sale of Class A common stock totaling $461,790 through two separate transactions on June 22 and June 23, 2026. The divestment was conducted under a Rule 10b5-1 trading plan established earlier in March 2026, a mechanism designed to facilitate predetermined stock sales regardless of market conditions. Concurrently, Leach exercised fully vested employee stock options to acquire an equivalent number of shares at a fixed exercise price, a standard practice that underscores the mechanical nature of the transaction rather than a discretionary market exit. The activity occurs against a backdrop of Ibotta's recent stock performance and its latest quarterly financial results, which revealed a significant earnings per share shortfall despite revenue meeting internal targets.

On June 22, Leach sold 11,187 shares at a weighted average price of $30.5619 per share. The execution occurred across multiple trades with prices fluctuating between $30.13 and $31.02. The following day, June 23, an additional 3,955 shares were liquidated at a weighted average price of $30.3146 per share, with individual trade prices ranging from $30.01 to $30.95. These sales were balanced by the acquisition of the same number of shares on the respective dates through the exercise of employee stock options. The options, which were fully vested and exercisable, carried an exercise price of $3.99 per share, resulting in a total acquisition value of $60,416. This parallel activity confirms the structured nature of the portfolio adjustment.

Following these transactions, Leach's direct holding stands at 866,484 shares of Ibotta Class A common stock. This portfolio includes restricted stock units (RSUs), which confer a contingent right to receive one share of Class A common stock subject to specific vesting schedules and conditions. The presence of these RSUs indicates a continued alignment of executive interests with long-term shareholder value, despite the recent cash realization from the Rule 10b5-1 plan.

The stock has demonstrated notable momentum in recent weeks, recording a 9.3% gain over the past week and a 43% surge over the last six months. At the time of reporting, the shares were trading at $31.98. This performance contrasts with the company's Q1 2026 earnings report, which showed a notable shortfall in earnings per share compared to analyst forecasts. Ibotta posted an EPS of $0.24, significantly below the projected $0.62, marking a 61.29% miss. Despite this earnings miss, Ibotta's revenue for the quarter was $82.5 million, which slightly exceeded the company's internal guidance but reflected a 2% decline compared to the same period last year.

Market reaction to these developments has been mixed but leans toward analytical caution. Needham has raised its price target for Ibotta to $45 from $33, maintaining a Buy rating. The firm attributed this increase to a higher target multiple, even as it modestly lowered estimates for 2026. Ibotta has consistently exceeded the top end of its guidance for three consecutive quarters following an initial shortfall post-IPO. This pattern suggests a divergence between operational execution and market expectations, a dynamic that requires careful monitoring of working-capital dynamics and backlog conversion in the broader digital advertising and consumer engagement sector.

Investors analyzing IBTA may find value in deeper insights, as some analysis suggests the stock appears undervalued at current levels. For comprehensive data, a Pro Research Report covering IBTA and 1,400+ other US equities is available. This report includes AI-picked strategies and reviews of key financial metrics. The intersection of executive trading activity, earnings volatility, and analyst revision highlights the complexity of valuing Ibotta in the current market environment.

Risks

  • The significant 61.29% earnings miss in Q1 2026 highlights potential volatility in Ibotta's profitability metrics, which could impact investor confidence in the digital consumer engagement sector.
  • Despite exceeding internal guidance for three consecutive quarters, the 2% revenue decline year-over-year raises questions about sustainable growth rates in a competitive market.
  • The reliance on analyst revisions and AI-driven valuation models introduces uncertainty regarding the stock's true intrinsic value, as seen in the divergence between the $31.98 market price and the $45 price target.

More from Insider Trading

CoreWeave Executives Divest Shares via Pre-Arranged Trust Structures Amidst Market Volatility Jun 24, 2026 Dyne Therapeutics Director Kersten Offloads $5.46 Million in Stock Jun 24, 2026 ICONIQ Strategic Partners Offloads $6.00M in ServiceTitan Shares Amid Market Volatility Jun 24, 2026 Nuvation Bio CRO Kerry Wentworth Disposes of $379k in Shares Amidst Corporate Developments Jun 24, 2026 Strategy Inc Director Patten Offloads Shares Following Option Exercise Jun 24, 2026